Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Interactions between neural decision-making circuits predict long-term dietary treatment success in obesity.

Weygandt M, Spranger J, Leupelt V, Maurer L, Bobbert T, Mai K, Haynes JD.

Neuroimage. 2019 Jan 1;184:520-534. doi: 10.1016/j.neuroimage.2018.09.058. Epub 2018 Sep 22.

PMID:
30253206
2.

Effects of a combined dietary, exercise and behavioral intervention and sympathetic system on body weight maintenance after intended weight loss: Results of a randomized controlled trial.

Mai K, Brachs M, Leupelt V, Jumpertz-von Schwartzenberg R, Maurer L, Grüters-Kieslich A, Ernert A, Bobbert T, Krude H, Spranger J.

Metabolism. 2018 Jun;83:60-67. doi: 10.1016/j.metabol.2018.01.003. Epub 2018 Jan 31.

PMID:
29360493
3.

Clinical and neurobiological effects of aerobic exercise in dental phobia: A randomized controlled trial.

Lindenberger BL, Plag J, Schumacher S, Gaudlitz K, Bischoff S, Bobbert T, Dimeo F, Petzold MB, Kirschbaum C, Dudás Z, Ströhle A.

Depress Anxiety. 2017 Nov;34(11):1040-1048. doi: 10.1002/da.22659. Epub 2017 May 26.

PMID:
28556577
4.

Renal function is independently associated with circulating betatrophin.

Maurer L, Schwarz F, Fischer-Rosinsky A, Schlueter N, Brachs S, Möhlig M, Pfeiffer A, Mai K, Spranger J, Bobbert T.

PLoS One. 2017 Mar 3;12(3):e0173197. doi: 10.1371/journal.pone.0173197. eCollection 2017.

5.

Weight Loss Partially Restores Glucose-Driven Betatrophin Response in Humans.

Maurer L, Brachs S, Decker AM, Brachs M, Leupelt V, Jumpertz von Schwartzenberg R, Ernert A, Bobbert T, Krude H, Spranger J, Mai K.

J Clin Endocrinol Metab. 2016 Nov;101(11):4014-4020. Epub 2016 Jul 26.

PMID:
27459526
6.

ANP system activity predicts variability of fat mass reduction and insulin sensitivity during weight loss.

Brachs M, Wiegand S, Leupelt V, Ernert A, Kintscher U, Jumpertz von Schwarzenberg R, Decker AM, Bobbert T, Hübner N, Chen W, Krude H, Spranger J, Mai K.

Metabolism. 2016 Jun;65(6):935-43. doi: 10.1016/j.metabol.2016.03.013. Epub 2016 Apr 7.

PMID:
27173472
7.

Chemerin and prediction of Diabetes mellitus type 2.

Bobbert T, Schwarz F, Fischer-Rosinsky A, Maurer L, Möhlig M, Pfeiffer AF, Mai K, Spranger J.

Clin Endocrinol (Oxf). 2015 Jun;82(6):838-43. doi: 10.1111/cen.12707. Epub 2015 Jan 30.

PMID:
25640450
8.

Effect of combined cognitive-behavioural therapy and endurance training on cortisol and salivary alpha-amylase in panic disorder.

Plag J, Gaudlitz K, Schumacher S, Dimeo F, Bobbert T, Kirschbaum C, Ströhle A.

J Psychiatr Res. 2014 Nov;58:12-9. doi: 10.1016/j.jpsychires.2014.07.008. Epub 2014 Jul 21.

PMID:
25085607
9.

Hepatic insulin clearance is closely related to metabolic syndrome components.

Pivovarova O, Bernigau W, Bobbert T, Isken F, Möhlig M, Spranger J, Weickert MO, Osterhoff M, Pfeiffer AF, Rudovich N.

Diabetes Care. 2013 Nov;36(11):3779-85. doi: 10.2337/dc12-1203. Epub 2013 Sep 11.

10.

Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy.

Bobbert P, Stellbaum C, Steffens D, Schütte C, Bobbert T, Schultheiss HP, Rauch U.

Blood Coagul Fibrinolysis. 2012 Dec;23(8):723-8. doi: 10.1097/MBC.0b013e32835824b3.

PMID:
23135379
11.

Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians.

Bobbert T, Schwarz F, Fischer-Rosinsky A, Pfeiffer AF, Möhlig M, Mai K, Spranger J.

Diabetes Care. 2013 Jan;36(1):145-9. doi: 10.2337/dc12-0703. Epub 2012 Aug 28.

12.

High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy.

Bobbert P, Jenke A, Bobbert T, Kühl U, Rauch U, Lassner D, Scheibenbogen C, Poller W, Schultheiss HP, Skurk C.

Eur J Heart Fail. 2012 Nov;14(11):1265-75. doi: 10.1093/eurjhf/hfs111. Epub 2012 Jul 4.

13.

Attachment style contributes to the outcome of a multimodal lifestyle intervention.

Kiesewetter S, Köpsel A, Mai K, Stroux A, Bobbert T, Spranger J, Köpp W, Deter HC, Kallenbach-Dermutz B.

Biopsychosoc Med. 2012 Feb 2;6(1):3. doi: 10.1186/1751-0759-6-3.

14.

A distinct metabolic signature predicts development of fasting plasma glucose.

Hische M, Larhlimi A, Schwarz F, Fischer-Rosinský A, Bobbert T, Assmann A, Catchpole GS, Pfeiffer AF, Willmitzer L, Selbig J, Spranger J.

J Clin Bioinforma. 2012 Feb 2;2:3. doi: 10.1186/2043-9113-2-3.

15.

Leptin and endocrine parameters in marathon runners.

Bobbert T, Mai K, Brechtel L, Schulte HM, Weger B, Pfeiffer AF, Spranger J, Diederich S.

Int J Sports Med. 2012 Mar;33(3):244-8. doi: 10.1055/s-0031-1291251. Epub 2012 Jan 19.

PMID:
22261828
16.

Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo.

Mai K, Andres J, Bobbert T, Assmann A, Biedasek K, Diederich S, Graham I, Larson TR, Pfeiffer AF, Spranger J.

Metabolism. 2012 Jan;61(1):108-16. doi: 10.1016/j.metabol.2011.05.018. Epub 2011 Jul 7.

PMID:
21741058
17.

Effects of hyperlipidaemia on glucocorticoid metabolism: results of a randomized controlled trial in healthy young women.

Mai K, Reinecke F, Andres J, Bobbert T, Kraatz J, Wudy SA, Hartmann MF, Maser-Gluth C, Pfeiffer AF, Spranger J.

Clin Endocrinol (Oxf). 2011 May;74(5):551-7. doi: 10.1111/j.1365-2265.2011.03972.x.

PMID:
21470279
18.

Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness.

Bobbert T, Raila J, Schwarz F, Mai K, Henze A, Pfeiffer AF, Schweigert FJ, Spranger J.

Atherosclerosis. 2010 Dec;213(2):549-51. doi: 10.1016/j.atherosclerosis.2010.07.063. Epub 2010 Aug 19.

PMID:
20832065
19.

Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin.

Mai K, Bobbert T, Groth C, Assmann A, Meinus S, Kraatz J, Andres J, Arafat AM, Pfeiffer AF, Möhlig M, Spranger J.

Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E126-30. doi: 10.1152/ajpendo.00020.2010. Epub 2010 Apr 27.

20.

Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction.

Mai K, Schwarz F, Bobbert T, Andres J, Assmann A, Pfeiffer AF, Spranger J.

Metabolism. 2011 Feb;60(2):306-11. doi: 10.1016/j.metabol.2010.02.016. Epub 2010 Apr 1.

PMID:
20362303
21.

Relation between physiological variation of renal function and carotid intima media thickness in non-diabetic individuals.

Bobbert T, Mai K, Fischer-Rosinský A, Osterhoff M, Pfeiffer AF, Spranger J.

J Atheroscler Thromb. 2010 Mar 31;17(3):242-8. Epub 2009 Dec 24.

22.

Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy.

Bobbert P, Weithäuser A, Andres J, Bobbert T, Kühl U, Schultheiss HP, Rauch U, Skurk C.

Eur J Heart Fail. 2009 Dec;11(12):1163-8. doi: 10.1093/eurjhf/hfp153.

23.

A1C is associated with intima-media thickness in individuals with normal glucose tolerance.

Bobbert T, Mai K, Fischer-Rosinsky A, Pfeiffer AF, Spranger J.

Diabetes Care. 2010 Jan;33(1):203-4. doi: 10.2337/dc09-1009. Epub 2009 Oct 6.

24.

Acute hyperinsulinaemia and hyperlipidaemia modify circulating adiponectin and its oligomers.

Bobbert T, Weicht J, Mai K, Möhlig M, Pfeiffer AF, Spranger J.

Clin Endocrinol (Oxf). 2009 Oct;71(4):507-11. doi: 10.1111/j.1365-2265.2008.03519.x.

PMID:
19751297
25.

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.

Mai K, Andres J, Biedasek K, Weicht J, Bobbert T, Sabath M, Meinus S, Reinecke F, Möhlig M, Weickert MO, Clemenz M, Pfeiffer AF, Kintscher U, Spuler S, Spranger J.

Diabetes. 2009 Jul;58(7):1532-8. doi: 10.2337/db08-1775. Epub 2009 Apr 28.

26.

High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus.

Bobbert P, Rauch U, Stratmann B, Goldin-Lang P, Antoniak S, Bobbert T, Schultheiss HP, Tschoepe D.

Diabetes Res Clin Pract. 2008 Nov;82(2):179-84. doi: 10.1016/j.diabres.2008.07.018. Epub 2008 Sep 7.

PMID:
18778866
27.

Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial.

Mai K, Bobbert T, Reinecke F, Andres J, Maser-Gluth C, Wudy SA, Möhlig M, Weickert MO, Hartmann MF, Schulte HM, Diederich S, Pfeiffer AF, Spranger J.

J Clin Endocrinol Metab. 2008 Oct;93(10):3900-6. doi: 10.1210/jc.2008-0714. Epub 2008 Jul 29.

PMID:
18664538
28.

Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.

Mai K, Andres J, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.

Clin Endocrinol (Oxf). 2007 Sep;67(3):419-25. Epub 2007 Jun 6.

PMID:
17555498
29.

Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters.

Engl J, Bobbert T, Ciardi C, Laimer M, Tatarczyk T, Kaser S, Weiss H, Molnar C, Tilg H, Patsch JR, Spranger J, Ebenbichler CF.

Obesity (Silver Spring). 2007 May;15(5):1172-8.

30.

The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: a human intervention study.

Beulens JW, van Loon LJ, Kok FJ, Pelsers M, Bobbert T, Spranger J, Helander A, Hendriks HF.

Diabetologia. 2007 Jul;50(7):1388-92. Epub 2007 May 11.

31.

Adiponectin oligomers in human serum during acute and chronic exercise: relation to lipid metabolism and insulin sensitivity.

Bobbert T, Wegewitz U, Brechtel L, Freudenberg M, Mai K, Möhlig M, Diederich S, Ristow M, Rochlitz H, Pfeiffer AF, Spranger J.

Int J Sports Med. 2007 Jan;28(1):1-8. Epub 2006 Nov 28.

PMID:
17133288
32.

No effect of free fatty acids on adrenocorticotropin and cortisol secretion in healthy young men.

Mai K, Bobbert T, Kullmann V, Andres J, Bähr V, Maser-Gluth C, Rochlitz H, Spranger J, Diederich S, Pfeiffer AF.

Metabolism. 2006 Aug;55(8):1022-8.

PMID:
16839836
33.

Free fatty acids increase androgen precursors in vivo.

Mai K, Bobbert T, Kullmann V, Andres J, Rochlitz H, Osterhoff M, Weickert MO, Bähr V, Möhlig M, Pfeiffer AF, Diederich S, Spranger J.

J Clin Endocrinol Metab. 2006 Apr;91(4):1501-7. Epub 2006 Jan 24.

PMID:
16434463
34.

Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men.

Möhlig M, Freudenberg M, Bobbert T, Ristow M, Rochlitz H, Weickert MO, Pfeiffer AF, Spranger J.

J Clin Endocrinol Metab. 2006 Mar;91(3):964-7. Epub 2005 Dec 29.

PMID:
16384847
35.

Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells.

Spranger J, Verma S, Göhring I, Bobbert T, Seifert J, Sindler AL, Pfeiffer A, Hileman SM, Tschöp M, Banks WA.

Diabetes. 2006 Jan;55(1):141-7.

36.

Adaptation of the hypothalamic-pituitary hormones during intensive endurance training.

Bobbert T, Brechtel L, Mai K, Otto B, Maser-Gluth C, Pfeiffer AF, Spranger J, Diederich S.

Clin Endocrinol (Oxf). 2005 Nov;63(5):530-6.

PMID:
16268805
37.

In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.

Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.

Clin Endocrinol (Oxf). 2005 Oct;63(4):442-9.

PMID:
16181237
38.

Changes of adiponectin oligomer composition by moderate weight reduction.

Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert MO, Möhlig M, Pfeiffer AF, Spranger J.

Diabetes. 2005 Sep;54(9):2712-9.

39.

[Significance of biomarkers for metabolic syndrome during weight reduction].

Rochlitz H, Akpulat S, Bobbert T, Mai K, Möhlig M, Osterhoff M, Weickert MO, Pfeiffer AF, Spranger J.

Dtsch Med Wochenschr. 2005 Apr 29;130(17):1061-6. German.

PMID:
15841420
40.

ERK1/2-dependent contractile protein expression in vascular smooth muscle cells.

Schauwienold D, Plum C, Helbing T, Voigt P, Bobbert T, Hoffmann D, Paul M, Reusch HP.

Hypertension. 2003 Mar;41(3):546-52. Epub 2003 Feb 3.

PMID:
12623957

Supplemental Content

Loading ...
Support Center